Treatment Options for ER+/HER2- Metastatic Breast Cancer

Communities›In Treatment For Breast Cancer›Treatment Options for ER+/HER2- Metastatic Breast Cancer

AL

Community Member

2 years ago

Hello I’m mbc since March 2019 I am Ear+ her2- I have used ibrance / letrozole for first 3 years Then cape Then taxol Now no treatment as having a break luckily Can yiy please tell Me other treatment lines there are for my type And also is there any new ones coming sooner Thank you

4

4 comments

Comment

Accepted Answer

Thank you for sharing your treatment journey and asking about future options for ER+/HER2- metastatic breast cancer. It's wonderful that you're currently able to take a treatment break and are thinking ahead about what might be available next. There are several additional treatment lines that oncologists typically consider for this type of breast cancer, including other CDK4/6 inhibitors, different hormone therapies, targeted therapies like mTOR inhibitors, and newer options that continue to be developed and approved. Your oncologist will be the best person to discuss which treatments might be most suitable for your specific situation and to keep you updated on any promising new therapies that may become available.

3+ patients found this helpful

SR

Community Member

6 months ago

Verzenio!!

RD

Community Member

6 months ago

I’m sorry for your diagnoses. Just out of curiosity did you have a recurrence in 2019 or new diagnosis?

1

B*

Community Member

6 months ago

Hi Alison. Thank you for posting here! You can speak directly to an Outcomes4Me oncology nurse practitioner: https://outcomes4me.app.link/Xtp4sCIl2rb

1

CA

Community Member

2 months ago

Thank you for sharing your treatment journey and asking about future options for ER+/HER2- metastatic breast cancer. It's wonderful that you're currently able to take a treatment break and are thinking ahead about what might be available next. There are several additional treatment lines that oncologists typically consider for this type of breast cancer, including other CDK4/6 inhibitors, different hormone therapies, targeted therapies like mTOR inhibitors, and newer options that continue to be developed and approved. Your oncologist will be the best person to discuss which treatments might be most suitable for your specific situation and to keep you updated on any promising new therapies that may become available.

Treatment Options for ER+/HER2- Metastatic Breast Cancer

Related Questions